Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the duroc/yorkshire porcine model of fibroproliferative scarring

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Engrav, Loren H ^a   Tuggle, Christopher K ^b   Kerr, Kathleen F ^c   Zhu, Kathy Q ^a   Numhom, Surawej ^a,d   Couture, Oliver P ^b   Beyer, Richard P ^c   Hocking, Anne M ^a   Carrougher, Gretchen J ^a   Ramos, Maria Luiza C ^a,e   Klein, Matthew B ^a   Gibran, Nicole S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; TRANSCRIPTOME;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DERMATOME; DNA MICROARRAY; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; HUMAN TISSUE; HYPERTROPHIC SCAR; LIMIT OF DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; SKIN FIBROSIS; SKIN PIGMENTATION; SWINE; WOUND HEALING; ANIMAL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; INJURY; PATHOLOGY; SCAR;

ANIMALIA; SUS;

ANIMALS; CICATRIX; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; SWINE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 79955462754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019024     Document Type: Article

References (78)

1. Warren JC, (1893) Hypertrophies and degenerations of cicatrices and cicatricial tissue. Transactions of the American Surgical Assoiation 11: 41-79.
2. Tredget EE, (1994) The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics. Ann Plast Surg 33: 152-154.
3. Ladak A, Tredget EE, (2009) Pathophysiology and management of the burn scar. Clin Plast Surg 36: 661-674.
4. Broerse JE, Zweekhorst MB, van Rensen AJ, de Haan MJ, (2010) Involving burn survivors in agenda setting on burn research: an added value? Burns 36: 217-231.
5. Shetlar MR, Shetlar CL, Hendricks L, Kischer CW, (1985) The use of athymic nude mice for the study of human keloids. Proceedings of the Society for Experimental Biology and Medicine 179: 549-552.
6. Robb EC, Waymack JP, Warden GD, Nathan P, Alexander JW, (1987) A new model for studying the development of human hypertrophic burn scar formation. Journal of Burn Care & Rehabilitation 8: 371-375.
7. Kischer CW, Pindur J, Shetlar MR, Shetlar CL, (1989) Implants of hypertrophic scars and keloids into the nude (athymic) mouse: viability and morphology. J Trauma 29: 672-677.
8. Kischer CW, Sheridan D, Pindur J, (1989) Use of nude (athymic) mice for the study of hypertrophic scars and keloids: vascular continuity between mouse and implants. Anat Rec 225: 189-196.
9. Shetlar MR, Shetlar CL, Kischer CW, Pindur J, (1991) Implants of keloid and hypertrophic scars into the athymic nude mouse: changes in the glycosaminoglycans of the implants. Connect Tissue Res 26: 23-36.
10. Mast BA, (1992) The skin. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical & clinical aspects Philadelphia W.B. Saunders Co.
11. Wolfort SF, Reiken SR, Berthiaume F, Tompkins RG, Yarmush ML, (1996) Control of hypertrophic scar growth using antibody-targeted photolysis. J Surg Res 62: 17-22.
12. Morris DE, Wu L, Zhao LL, Bolton L, Roth SI, et al. (1997) Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plastic and Reconstructive Surgery 100: 674-681.
13. Reiken SR, Wolfort SF, Berthiaume F, Compton C, Tompkins RG, et al. (1997) Control of hypertrophic scar growth using selective photothermolysis. Lasers Surg Med 21: 7-12.
14. Polo M, Kim YJ, Kucukcelebi A, Hayward PG, Ko F, et al. (1998) An in vivo model of human proliferative scar. J Surg Res 74: 187-195.
15. Wang X, Smith P, Pu LL, Kim YJ, Ko F, et al. (1999) Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 87: 194-200.
16. Polo M, Smith PD, Kim YJ, Wang X, Ko F, et al. (1999) Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 43: 185-190.
17. Aksoy MH, Vargel I, Canter IH, Erk Y, Sargon M, et al. (2002) A new experimental hypertrophic scar model in guinea pigs. Aesthetic Plastic Surgery 26: 388-396.
18. Ha X, Li Y, Lao M, Yuan B, Wu CT, (2003) Effect of human hepatocyte growth factor on promoting wound healing and preventing scar formation by adenovirus-mediated gene transfer. Chin Med J (Engl) 116: 1029-1033.
19. Cuttle L, Kempf M, Phillips GE, Mill J, Hayes MT, et al. (2006) A porcine deep dermal partial thickness burn model with hypertrophic scarring. Burns 32: 806-820.
20. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, et al. (2007) Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB Journal 21: 3250-3261.
21. Robson MC, Steed DL, Franz MG, (2001) Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg 38: 72-140.
22. Cole J, Tsou R, Wallace K, Gibran NS, Isik FF, (2001) Early gene expression profile of human skin to injury using high-density cDNA microarrays. Wound Repair Regen 9: 360-370.
23. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J, (1983) Hypertrophic burn scars: Analysis of variables. Journal of Trauma 23: 895-898.
24. McDonald WS, Deitch EA, (1987) Hypertrophic skin grafts in burned patients: a prospective analysis of variables. J Trauma 27: 147-150.
25. Spurr ED, Shakespeare PG, (1990) Incidence of hypertrophic scarring in burn-injured children. Burns 16: 179-181.
26. Bombaro KM, Engrav LH, Carrougher GJ, Wiechman SA, Faucher L, et al. (2003) What is the prevalence of hypertrophic scarring following burns? Burns 29: 299-302.
27. Zhu KQ, Engrav LH, Gibran NS, Cole JK, Matsumura H, et al. (2003) The female, red Duroc pig as an animal model of hypertrophic scarring and the potential role of the cones of skin. Burns 29: 649-664.
28. Zhu KQ, Engrav LH, Tamura RN, Cole JA, Muangman P, et al. (2004) Further similarities between cutaneous scarring in the female, red Duroc pig and human hypertrophic scarring. Burns 30: 518-530.
29. Liang Z, Engrav LH, Muangman P, Muffley LA, Zhu KQ, et al. (2004) Nerve quantification in female red Duroc pig (FRDP) scar compared to human hypertrophic scar. Burns 30: 57-64.
30. Zhu KQ, Engrav LH, Armendariz R, Muangman P, Klein MB, et al. (2005) Changes in VEGF and nitric oxide after deep dermal injury in the female, red Duroc pig-further similarities between female, Duroc scar and human hypertrophic scar. Burns 31: 5-10.
31. Harunari N, Zhu KQ, Armendariz RT, Deubner H, Muangman P, et al. (2006) Histology of the thick scar on the female, red Duroc pig: Final similarities to human hypertrophic scar. Burns 32: 669-677.
32. Xie Y, Zhu KQ, Deubner H, Emerson DA, Carrougher GJ, et al. (2007) The microvasculature in cutaneous wound healing in the female red Duroc pig is similar to that in human hypertrophic scars and different from that in the female Yorkshire pig. J Burn Care Res 28: 500-506.
33. Zhu KQ, Carrougher GJ, Gibran NS, Isik FF, Engrav LH, (2007) Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring. Wound Repair Regen 15 (Suppl 1): S32-39.
34. Zhu KQ, Carrougher GJ, Couture OP, Tuggle CK, Gibran NS, et al. (2008) Expression of collagen genes in the cones of skin in the Duroc/Yorkshire porcine model of fibroproliferative scarring. J Burn Care Res 29: 815-827.
35. Gallant CL, Wright JB, Olson ME, Hart DA, (2001) The red Duroc pig model of hypertrophic wound healing. Albuquerque, NM.
36. Gallant CL, Hart DA, Olson ME, (2002) Skin wound healing in red Duroc pigs: Potential role of growth factors and cytokines in scar formation. Baltimore, MD.
37. Gallant CL, Olson ME, Hart DA, (2002) Full- and partial-thickness skin wounds in red Duroc pigs leads to hypercontracted, hyperpigmented scars. Baltimore, MD.
38. Gallant CL, Olson ME, Hart DA, (2004) Molecular, histologic, and gross phenotype of skin wound healing in red Duroc pigs reveals an abnormal healing phenotype of hypercontracted, hyperpigmented scarring. Wound Repair Regen 12: 305-319.
39. Gallant-Behm CL, Olson ME, Hart DA, (2005) Cytokine and growth factor mRNA expression patterns associated with the hypercontracted, hyperpigmented healing phenotype of red duroc pigs: a model of abnormal human scar development? J Cutan Med Surg 9: 165-177.
40. Gallant-Behm CL, Hart DA, (2006) Genetic analysis of skin wound healing and scarring in a porcine model. Wound Repair Regen 14: 46-54.
41. Gallant-Behm CL, Tsao H, Reno C, Olson ME, Hart DA, (2006) Skin wound healing in the first generation (F1) offspring of Yorkshire and red Duroc pigs: evidence for genetic inheritance of wound phenotype. Burns 32: 180-193.
42. Gallant-Behm CL, Reno C, Tsao H, Hart DA, (2007) Genetic involvement in skin wound healing and scarring in domestic pigs: assessment of molecular expression patterns in (Yorkshire x Red Duroc) x Yorkshire backcross animals. J Invest Dermatol 127: 233-244.
43. de Hemptinne I, Gallant-Behm CL, Noack CL, Parreno J, Hart DA, (2008) Dermal fibroblasts from red Duroc and Yorkshire pigs exhibit intrinsic differences in the contraction of collagen gels. Wound Repair Regen 16: 132-142.
44. Gallant-Behm CL, Hildebrand KA, Hart DA, (2008) The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs. Wound Repair Regen 16: 226-233.
45. Mak K, Manji A, Gallant-Behm C, Wiebe C, Hart DA, et al. (2009) Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model. J Dermatol Sci.
46. Wong JW, Gallant-Behm C, Wiebe C, Mak K, Hart DA, et al. (2009) Wound healing in oral mucosa results in reduced scar formation as compared with skin: evidence from the red Duroc pig model and humans. Wound Repair Regen 17: 717-729.
47. Shoemaker JV, (1905) A Practical Treatise on Diseases of the Skin. New York and London D. Appleton and Company.
48. Jackson DM, (1953) The diagnosis of the depth of burning. British Journal of Surgery 40: 588-596.
49. Matsumura H, Engrav LH, Reichenbach D, Gibran NS, Maser B, (1998) Cones, fat domes and hypertrophic scarring in the female, red Duroc pig. Plastic Surgery Research Council, Loma Linda pp. 47-50.
50. Matsumura H, Engrav LH, Gibran NS, Yang TM, Grant JH, et al. (2001) Cones of skin occur where hypertrophic scar occurs. Wound Repair and Regeneration 9: 269-277.
51. Santucci M, Borgognoni L, Reali UM, Gabbiani G, (2001) Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 438: 457-463.
52. Couture O, Callenberg K, Koul N, Pandit S, Younes R, et al. (2009) ANEXdb: an integrated animal ANnotation and microarray EXpression database. Mamm Genome 20: 768-777.
53. Bourgon R, Gentleman R, Huber W, (2010) Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A 107: 9546-9551.
54. Baugh LR, Hill AA, Brown EL, Hunter CP, (2001) Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 29: E29.
55. Cui D, Dougherty KJ, Machacek DW, Sawchuk M, Hochman S, et al. (2006) Divergence between motoneurons: gene expression profiling provides a molecular characterization of functionally discrete somatic and autonomic motoneurons. Physiol Genomics 24: 276-289.
56. Hornik K, (2009) The R FAQ.
57. Gentleman RC, Rossini AJ, Dudoit S, Hornik K, (2009) Bioconductor FAQ.
58. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
59. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy-Analysis of Affymetrix GeneChip Data at the Probe Level. Bioinformatics 20: 307-315.
60. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F, (2004) A model-based background adjustment for oligonucleotide expression arrays. Journal of the American Statistical Association 99: 909-917.
61. Wu H, Kerr MK, Cui X, Churchill GA, (2003) Maanova: A software package for the analysis of spotted cDNA microarray experiements. In: Parmigiani G, Garrett ES, Irizarry R, Zeger SL, editors. The Analysis of Gene Expression Data New York Springer-Verlag New York, Inc pp. 313-341.
62. Storey JD, (2003) The positive false discovery rate: A bayesian interpretation and the q-value. The Annals of Statistics 31: 2013-2035.
63. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, et al. (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 4: R28.
64. Falcon S, Gentleman R, (2007) Using GOstats to test gene lists for GO term association. Bioinformatics 23: 257-258.
65. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
66. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
67. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP, (2007) GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23: 3251-3253.
68. Efron B, Tibshirani, (2007) On testing the significance of sets of genes. The Annals of Applied Statistics 1: 107-129.
69. Kischer CW, Bailey JF, (1972) The mast cell in hypertrophic scars. Texas Reports on Biology and Medicine 30: 327-338.
70. Kischer CW, Shetlar MR, Chvapil M, (1982) Hypertrophic scars and keloids: a review and new concept concerning their origin. Scan Electron Microsc pp. 1699-1713.
71. Massague J, (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6: 597-641.
72. Wassermann RJ, Polo M, Smith P, Wang X, Ko F, et al. (1998) Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res 75: 74-80.
73. Dabiri G, Tumbarello DA, Turner CE, Van de Water L, (2008) Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop. J Invest Dermatol 128: 2518-2525.
74. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
75. Ryge J, Westerdahl AC, Alstrom P, Kiehn O, (2008) Gene expression profiling of two distinct neuronal populations in the rodent spinal cord. PLoS One 3: e3415.
76. King C, Guo N, Frampton GM, Gerry NP, Lenburg ME, et al. (2005) Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays. J Mol Diagn 7: 57-64.
77. Silverstein P, Goodwin MN Jr, Raulston GL, (1972) Hypertrophic scarring, etiology and control of a disabling complication in burned soldiers. Ann Res Progress Report of the US Army Institute of Surgical Research Section 37, 30 June 1972 pp. 1-5.
78. Silverstein P, Goodwin MN, Raulston GL, Pruitt B, (1976) Hypertrophic scar in the experimental animal. In: Longacre JJ, editors. The ultrastructure of collagen; its relation to the healing of wounds and to the management of hypertrophic scar Springfield, IL Thomas pp. 213-236.